Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

50

Revenue 2017

Levemir

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Levemir was produced by Novo Nordisk.

New drugs drive Novo Nordisk despite insulin price pressures

New drugs drive Novo Nordisk despite insulin price pressures

scrutinised. Sales in Novo's insulin franchise have flat-lined as sales of its newer products were off-set by pricing pressure on its older products, such as Levemir (insulin detemir).

Novo bolstered by new diabetes, obesity products

Novo bolstered by new diabetes, obesity products Sales of long-acting insulin also decreased by 2%, which was driven by declining Levemir sales.

Novo Nordisk preps for speedy oral GLP-1 drug filing

Novo Nordisk preps for speedy oral GLP-1 drug filing products. Long-acting insulin sales shrank 6% to 20.8bn krone overall, mainly due to a sharp decline in top-seller Levemir (insulin detemir) which fell 21%, although there was a

Novo Nordisk’s Ozempic is quick out of the blocks, chasing Lilly’s Trulicity

Novo Nordisk’s Ozempic is quick out of the blocks, chasing Lilly’s Trulicity Xultophy’s performance helped prop up the insulin category as it copes with a slide in sales of top seller Levemir (insulin detemir), which shrank by almost a quarter to

Novo says real-world data backs its insulin switching

Novo says real-world data backs its insulin switching It showed that switching to Tresiba (insulin from another basal insulin - mainly Sanofi's Lantus (insulin glargine U100) or Novo's own Levemir (insulin detemir) brand - improved blood glucose control and

1 2 3 4 5 6 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...